Hotgen(SH:688068) Xin Lang Cai Jing·2025-10-17 02:03Group 1 - The core point of the news is that Hotgen Biotech's stock price increased by 5.26% to 186.64 CNY per share, with a total market capitalization of 17.303 billion CNY as of the report date [1] - Hotgen Biotech, established on June 23, 2005, specializes in the research, development, production, and sales of in vitro diagnostic reagents and instruments, with its main revenue sources being testing reagents (70.87%), testing instruments (19.79%), and others (8.17%) [1] Group 2 - According to data, Guotou Ruijin Fund holds a significant position in Hotgen Biotech, with its fund, Guotou Ruijin SSE Sci-Tech Innovation Board 200 Index Initiation A (023518), owning 13,400 shares, representing 1.12% of the fund's net value, making it the third-largest holding [2] - The fund has a total size of 70.0747 million CNY and has achieved a return of 29.04% since its inception on March 18, 2025 [2] - The fund managers, Zhao Jian and Qian Han, have significant experience, with Zhao having a tenure of 12 years and Qian 2 years, managing assets of 3.848 billion CNY and 936 million CNY respectively [2]